Literature DB >> 4013970

Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features.

J Wynn, N Fineberg, L Matzer, X Cortada, W Armstrong, J C Dillon, E L Kinney.   

Abstract

The records of 64 patients with progressive systemic sclerosis (PSS) were reviewed. More than 100 items from the patient's history, physical examination, and laboratory tests were encoded. A two-tailed Gehan's test was used to evaluate the effect of each variable on patient survival. Variables significant at the 0.05 level were then analyzed simultaneously, using the Cox regression model, in order to determine which clinical features are most predictive of survival in PSS. By Cox regression, the presence of an S3 gallop and advanced age at onset of PSS related negatively to survival. The relative risk of death for a patient with an S3 gallop was 5.44 (ratio of risk) times that for a patient without an S3 gallop, and the risk of death for a 70-year-old patient at disease onset was 20 times that of a 20-year-old patient at disease onset. In addition, when patient selection was taken into account, corticosteroid administration had a significant effect, and seemed to actually shorten survival. Although one of the factors, age at onset, is not modifiable, the presence of either variable should alert the clinician to the patient being at high risk for short survival. The application of this technique should also prove helpful in analyzing the efficacy of various proposed therapies.

Entities:  

Mesh:

Year:  1985        PMID: 4013970     DOI: 10.1016/0002-8703(85)90525-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

1.  Systemic sclerosis in the elderly.

Authors:  L Czirják; Z Nagy; G Szegedi
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

2.  Predictors of survival in 171 patients with systemic sclerosis (scleroderma).

Authors:  Z Nagy; L Czirják
Journal:  Clin Rheumatol       Date:  1997-09       Impact factor: 2.980

Review 3.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

4.  Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma.

Authors:  Robyn T Domsic; Tatiana Rodriguez-Reyna; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2010-08-02       Impact factor: 19.103

5.  Differences in presentation of younger and older systemic sclerosis patients in clinical trials.

Authors:  H H Weng; V K Ranganath; M Oh; G S Park; D Khanna; P J Clements; J R Seibold; D A Elashoff; D E Furst
Journal:  Clin Exp Rheumatol       Date:  2010-11-03       Impact factor: 4.473

6.  Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.

Authors:  C P Simeon; L Armadans; V Fonollosa; M Vilardell; J Candell; C Tolosa; F Mearin; M J Rodrigo; R Solans; J Lima; G Sampol
Journal:  Ann Rheum Dis       Date:  1997-12       Impact factor: 19.103

7.  Left ventricular wall thickness and disease duration in systemic sclerosis.

Authors:  I Hegedüs; L Czirják
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

8.  Systemic sclerosis in Iceland. A nationwide epidemiological study.

Authors:  A J Geirsson; K Steinsson; S Guthmundsson; V Sigurthsson
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

9.  Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.

Authors:  Robyn T Domsic; Svetlana I Nihtyanova; Stephen R Wisniewski; Michael J Fine; Mary Lucas; C Kent Kwoh; Christopher P Denton; Thomas A Medsger
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

10.  Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis.

Authors:  I Hegedüs; L Czirják
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.